Lv11
48 积分 2025-08-29 加入
Lu-177-Labeled Hetero-Bivalent Agents Targeting PSMA and Bone Metastases for Radionuclide Therapy
5天前
已完结
Bone metastasis: mechanisms, therapies, and biomarkers
5天前
已完结
Theranostic Agent Targeting Bone Metastasis: A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate
5天前
已完结
Development and Preclinical Evaluation of Dual-Target 68Ga/177Lu-Labeled FAP-Bisphosphonate Radioligands with Enhanced Osteoma Retention
6天前
已完结
Pre vivo, ex vivo and in vivo evaluations of [68Ga]-EDTMP
25天前
已完结
CD38 as theranostic target in oncology
1个月前
已完结
Peptide-Based ROR1-Targeting PET Ligands for Melanoma Tumor Imaging: Design and Preclinical Evaluation
1个月前
已完结
Real‐Time Detection of Reduced Nitroreductase with a Reversible Fluorescent Probe
3个月前
已完结
Novel CDTA-based, Bifunctional Chelators for Stable and Inert MnII Complexation: Synthesis and Physicochemical Characterization
4个月前
已完结
Activatable Magnetic Resonance Imaging Agents for Myeloperoxidase Sensing: Mechanism of Activation, Stability, and Toxicity
5个月前
已完结
皖公网安备34019202002308
